AK Medical Holdings Limited (1789.HK)

HKD 4.76

(-1.65%)

Market Cap (In HKD)

5.31 Billion

Revenue (In HKD)

1.09 Billion

Net Income (In HKD)

182.1 Million

Avg. Volume

2.35 Million

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.49-6.46
PE
-
EPS
-
Beta Value
-0.756
ISIN
KYG020141019
CUSIP
G02014101
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Zhijiang Li
Employee Count
-
Website
https://www.ak-medical.net
Ipo Date
2017-12-20
Details
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement implants; and 3D-printed products, such as 3D-printed hip replacement implants, 3D-printed artificial vertebral bodies, and 3D-printed spinal interbody cages. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.